Buy Cipla, positive on its performance: Dilip Bhat

Dilip Bhat of Prabhudas Lilladher told CNBC-TV18, "Even if you were to take out the one time impact of Nexium, I think the overall performance in Cipla still has been pretty strong. However that is in absolute terms. On a relative basis the valuation seems to be ahead of the current prices. More and more people are buying into this particular argument that this is a company which probably is ready to show 15-20 percent CAGR on the bottomline for the next couple of years. That kind of confidence and traction seems to be coming up on Cipla.""So, I would look to buy Cipla from the current level or even at dips. On slightly longer term basis, I remain quite positive on Cipla and its performance," he added.